The SMPD1 gene gives your body instructions to make acid sphingomyelinase, an enzyme that breaks down a fatty substance inside the cell’s recycling centers. This gene plays an important role in keeping fats from building up where they should not. If the gene does not work well, these fats can collect in organs such as the liver, spleen, lungs, and sometimes the brain, leading to Niemann-Pick disease types A or B. Effects can vary a lot depending on the variant.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the code for proteins, the parts of cells that do the work. Others mainly direct when certain processes occur, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in LearnHub.
Overview
SMPD1Gene function
What if the gene works
The SMPD1 gene helps cells break down a fatty substance called sphingomyelin inside lysosomes, the cell’s recycling centers. This supports normal fat balance and helps many tissues, including the brain, liver, and spleen, work as expected.
Risk
What if the gene does not work
Variants in the SMPD1 gene can cause acid sphingomyelinase deficiency. More severe variants often lead to early nerve damage plus enlarged liver and spleen, while milder variants may mainly affect the liver, spleen, and lungs.
Treatment
What does that mean for your treatment
A pathogenic variant in the SMPD1 gene can make someone eligible for olipudase alfa, an enzyme replacement therapy for the non-neurologic features of acid sphingomyelinase deficiency. It can improve lung function and reduce liver and spleen enlargement, but it does not treat brain involvement, so treatment for forms affecting the brain remains supportive.
Conditions associated with SMPD1
Gene function
What if the gene works
Your cells constantly replace old membrane material and recycle what they no longer need. The SMPD1 gene supports that daily cleanup by helping process sphingomyelin, a fatty substance found in cell membranes. This is a central part of what the SMPD1 gene does in normal cell function.
The SMPD1 gene gives cells instructions for a protein that breaks down sphingomyelin. This step mainly happens inside lysosomes (the cell's recycling compartments).
When cell membranes are worn out and replaced, this gene helps cells recycle part of their fatty material. That supports steady turnover and cleanup in many tissues.
This process makes ceramide, a fat that helps organize cell membranes and supports normal cell messages. Keeping a regular supply helps cells carry out routine tasks in a balanced way.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SMPD1 gene can change the acid sphingomyelinase enzyme so it folds poorly, is unstable, or has much lower activity, allowing sphingomyelin to build up inside the cell’s recycling compartments. In understanding how SMPD1 gene variants affect cell function, milder variants may leave some enzyme activity, while more severe variants leave little or none. This range often matches acid sphingomyelinase deficiency, with lower residual activity linked to earlier onset and broader, more severe features.
How variants are linked to conditions
Pathogenic variants in the SMPD1 gene cause acid sphingomyelinase deficiency, a condition that includes forms historically called Niemann-Pick disease type A and type B. People with this diagnosis may have an enlarged liver or spleen, lung problems, growth concerns, or changes in the nervous system, depending on the variant. Some SMPD1 variants have also been linked to a higher risk of Parkinson disease, but this association does not mean Parkinson disease will develop.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widespread in the general population. Most do not have a direct effect on health and instead are part of natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SMPD1, risk is mostly set by the variants you inherit. It is higher in families with a known SMPD1 change, and some SMPD1-related conditions are more common in people of Ashkenazi Jewish ancestry. Lifestyle habits do not meaningfully change whether this genetic condition occurs.
Inheritance of SMPD1 variants
SMPD1-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops disease only when they inherit two disease-causing variants in the SMPD1 gene, one from each parent. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a child who is also a carrier, and a 25% chance of resulting in a child without either variant. In families asking about the inheritance of SMPD1 gene variants, sons and daughters are affected at the same rate.
What does my SMPD1 result mean for my family?
For SMPD1, family implications are usually most relevant for relatives who could also be carriers. Brothers and sisters of someone with an SMPD1-related condition may also have the condition or be carriers, and other close relatives may carry the gene change as well. This can matter for family planning, especially if both parents in a couple carry an SMPD1 change.
Genetic information
Genetic testing
How you find out about variants
SMPD1 genetic testing usually uses a blood or saliva sample to read the SMPD1 gene and look for variants. Results may identify a disease causing variant, show no relevant variant, or find a variant of uncertain significance, which means the effect is not yet clear.
When should I consider getting a genetic test?
Consider SMPD1 testing if there is a family history of Niemann-Pick disease types A or B, or if someone has an enlarged liver or spleen, low platelets, lung problems, or delayed growth without a clear cause. It can also help show whether family members carry the same gene change when one relative is already known to have an SMPD1 change.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but what it can tell you varies based on the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication works well for one person, has less effect for another, or causes more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can shape a person’s response to medication. By studying links between genes and specific drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes can affect both how the body handles a drug and how strong its effects are. This information can support treatment decisions that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SMPD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
SMPD1 entered medical history through the study of Niemann-Pick disease in the early 1900s, when physicians first described children and adults with enlarged spleens, liver problems, and other shared features. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition was gradually separated into different types as laboratory methods improved. In the 1960s and 1970s, researchers connected types A and B to low acid sphingomyelinase activity, which narrowed the search for the underlying cause. Building on this early work, scientists identified the SMPD1 gene in the 1990s and confirmed that inherited variants in this gene explained acid sphingomyelinase deficiency. That discovery helped bring more accurate diagnosis, family testing, and clearer classification of related conditions.